Cite
Intra-peritoneal CAR-T cell therapy shows promising results in a murine model of epithelial ovarian cancer (313).
MLA
Laskov, Ido, et al. “Intra-Peritoneal CAR-T Cell Therapy Shows Promising Results in a Murine Model of Epithelial Ovarian Cancer (313).” Gynecologic Oncology, vol. 166, Aug. 2022, p. S164. EBSCOhost, https://doi.org/10.1016/S0090-8258(22)01536-0.
APA
Laskov, I., Deshet-Unger, N., Waks, T., Michaan, N., Raz, Y., Katz, B.-Z., Grisaru, D., & Levin, A. G. (2022). Intra-peritoneal CAR-T cell therapy shows promising results in a murine model of epithelial ovarian cancer (313). Gynecologic Oncology, 166, S164. https://doi.org/10.1016/S0090-8258(22)01536-0
Chicago
Laskov, Ido, Naamit Deshet-Unger, Tova Waks, Nadav Michaan, Yael Raz, Ben-Zion Katz, Dan Grisaru, and Anat Globerson Levin. 2022. “Intra-Peritoneal CAR-T Cell Therapy Shows Promising Results in a Murine Model of Epithelial Ovarian Cancer (313).” Gynecologic Oncology 166 (August): S164. doi:10.1016/S0090-8258(22)01536-0.